Adult medical-surgical ward patients. An automated score predicts the risk of deterioration (unplanned ICU transfer or death) within the next 12 hours. Alerts are reviewed by specially trained remote nurses, who contact the bedside rapid-response team; scores are not shown directly to bedside staff.
Developed and used internally by Kaiser Permanente Northern California. No FDA clearance or CE marking reported in the sources reviewed (November 2026).
Developer-led evaluation: Escobar GJ et al., NEJM 2020;383:1951-60. Staggered deployment across 21 hospitals (2013-2019), observational design. 30-day mortality after an alert 15.8% vs 20.4% in comparison patients; adjusted relative risk 0.84 (95% CI 0.78-0.90). ICU admission 17.7% vs 20.9%.
In routine use in Kaiser Permanente Northern California hospitals: pilot in 2 hospitals from 2013, then staggered rollout to 19 further hospitals between August 2016 and February 2019.
– Evaluated by the team that built it; no independent external validation identified.
– Observational, staggered rollout rather than a randomised trial: residual confounding is possible.
– The benefit depends on the organisational model (dedicated remote nurse team, rapid-response escalation), not on the score alone.
– Built and calibrated on one integrated health system; performance elsewhere would need local validation.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.
